PUMA BIOTECHNOLOGY, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Los Angeles, CA
SEC filing record 1 source field available
Fiscal year end
31 December
PUMA BIOTECHNOLOGY, INC. has filed 1,115 SEC EDGAR filings since 14 Sep 2007

SEC filing history

Showing 676-700 of 1,000 matching filings.

Per page
25
Current page
28
8-K File 001-35703

8-K

Filing date
22 Nov 2017
Reporting date
20 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

FORM 8-K

Filing date
09 Nov 2017
Reporting date
09 Nov 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

FORM 8-K

Filing date
06 Nov 2017
Reporting date
31 Oct 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
02 Oct 2017
Reporting date
29 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Sep 2017
Reporting date
06 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

FORM 8-K

Filing date
08 Sep 2017
Reporting date
08 Sep 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

ADAGE CAPITAL PARTNERS GP, L.L.C.

Filing date
07 Sep 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-83367

PBYI AS OF 07/31/2017

Filing date
10 Aug 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

8-K

Filing date
09 Aug 2017
Reporting date
09 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

8-K

Filing date
02 Aug 2017
Reporting date
31 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2017
Reporting date
20 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2017
Reporting date
20 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2017
Reporting date
20 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
24 Jul 2017
Reporting date
20 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-219347

S-8

Filing date
19 Jul 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

FORM 8-K

Filing date
19 Jul 2017
Reporting date
17 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jul 2017
Reporting date
03 Jul 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
14 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-35703

8-K

Filing date
14 Jun 2017
Reporting date
12 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PUMA BIOTECHNOLOGY, INC..

Filing date
12 Jun 2017
Reporting date
08 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .